Skip to content

Electrode Using Promeon RG-60 Series Gel

by Labeltape Meditect, Inc.

510(k) K915333

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK915333 Date14 Jan 1992ClearedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-0500-2013 FDA Class II initiated 9 Feb 2012

    Covidien is conducting a voluntary recall regarding specific lots of TENS electrodes because it was determined that during the manufacturing process the surface of the wires in these lots may have been exposed to an employee who had a minor cut.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GXY
Device Class
Class II
Regulation
21 CFR Part 882.1320
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a cutaneous electrode, designed for non-invasive electrical stimulation and recording of neural activity. It incorporates the Promeon RG-60 Series Gel to enhance conductivity and ensure reliable signal transmission during electrophysiological procedures. Primarily used in neurology, it facilitates applications such as electromyography (EMG), electroencephalography (EEG), and nerve conduction studies. The electrode adheres to the skin and maintains a stable interface for diagnostic or monitoring purposes.

The electrode is supplied as a single-use item, intended for sterile application in clinical settings. It is classified under FDA product code GXY and has received FDA 510(k) clearance (K915333) as substantially equivalent to a predicate device. No specific MRI safety labeling is indicated, and storage conditions are not detailed in the regulatory submission. The device is intended for professional use by trained healthcare personnel in neurology-related diagnostics.

Other devices from Labeltape Meditect, Inc.

See all devices from Labeltape Meditect, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Promeon RG-60 Gel Electrode used for?

    The Promeon RG-60 Gel Electrode is designed for non-invasive electrical stimulation and recording of neural activity. It is specifically used in neurology for procedures like electromyography (EMG), electroencephalography (EEG), and nerve conduction studies. The gel enhances conductivity, ensuring stable signal transmission during diagnostic or monitoring applications.

  • Is the electrode single-use or reusable?

    The electrode is supplied as a single-use item, intended for sterile application in clinical settings. This design ensures patient safety and hygiene by preventing cross-contamination between uses.

  • What are the key features of the Promeon RG-60 Gel?

    The Promeon RG-60 Series Gel is incorporated into the electrode to improve conductivity, which is essential for reliable signal transmission during electrophysiological procedures. This enhances the accuracy and consistency of readings in EMG, EEG, and nerve conduction studies.

  • Who should use this electrode?

    This electrode is intended for professional use by trained healthcare personnel in neurology-related diagnostics. It is not designed for home use or self-administration.

  • What regulatory approval does the electrode hold?

    The electrode has received FDA 510(k) clearance (K915333) as substantially equivalent to a predicate device, classified under FDA product code GXY. This clearance confirms its compliance with U.S. regulatory standards for use in clinical electrophysiological procedures.